drugset / Trial / NCT00410033

Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin

NCT00410033

Completed 74 enrolled Novo Nordisk A/S
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This trial is conducted in Europe. This is a single-centre, retrospective trial aiming at comparing the antibody levels in children and adolescents.

Timeline

Start
1989-12
Primary completion
2006-05
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin aspart Protein / enzyme biologic
Subject soluble human insulin Unknown
Background isophane human insulin Protein / enzyme biologic